These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18686749)

  • 1. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence.
    Romanelli M; Dini V; Vowden P; Agren MS
    Clin Interv Aging; 2008; 3(2):263-72. PubMed ID: 18686749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers.
    Vowden P; Romanelli M; Price P
    J Wound Care; 2007 May; 16(5):189-95. PubMed ID: 17552400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers: follow-up data.
    Romanelli M; Kaha E; Stege H; Wnorowski JW; Vowden P; Majamaa H; Lazaro JL
    J Wound Care; 2008 Jan; 17(1):17-8, 20-3. PubMed ID: 18210952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers.
    Vowden P; Romanelli M; Peter R; Boström A; Josefsson A; Stege H
    Wound Repair Regen; 2006; 14(3):240-6. PubMed ID: 16808801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of amelogenin protein in the treatment of hard-to-heal wounds.
    Chadwick P; Acton C
    Br J Nurs; 2009 Mar 26-Apr 8; 18(6):S22, S24, S26, passim. PubMed ID: 19374040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
    Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
    J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amelogenin ECM protein on the healing of chronic leg ulcers with atrophie blanche.
    Fogh K; Nielsen CB; Dam W
    J Wound Care; 2012 Dec; 21(12):612-4. PubMed ID: 23299272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for helping people adhere to compression treatments for venous leg ulceration.
    Weller CD; Buchbinder R; Johnston RV
    Cochrane Database Syst Rev; 2013 Sep; (9):CD008378. PubMed ID: 24009097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into therapy by mathematical analysis: recalcitrant granulated improved more than sclerotic venous leg ulcers with amelogenin treatment.
    Renner R; Simon JC
    J Dermatol Sci; 2012 Jul; 67(1):15-9. PubMed ID: 22608215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of an acellular synthetic matrix in the treatment of hard-to-heal leg ulcers.
    Harding K; Aldons P; Edwards H; Stacey M; Finlayson K; Gibb M; Jenkins L; Shooter G; Lonkhuyzen DV; Lynam E; Heinrichs EL; Upton Z
    Int Wound J; 2014 Apr; 11(2):129-37. PubMed ID: 23834253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it time to re-appraise the role of compression in non-healing venous leg ulcers?
    Guest JF; Charles H; Cutting KF
    J Wound Care; 2013 Sep; 22(9):453-60. PubMed ID: 24005778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline for treating venous leg ulcers.
    Jull A; Arroll B; Parag V; Waters J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001733. PubMed ID: 17636683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, controlled trial comparing the effects of noncontact, low-frequency ultrasound to standard care in healing venous leg ulcers.
    Gibbons GW; Orgill DP; Serena TE; Novoung A; O'Connell JB; Li WW; Driver VR
    Ostomy Wound Manage; 2015 Jan; 61(1):16-29. PubMed ID: 25581604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effectiveness and cost of treatment with humid environment as compared to traditional cure. Clinical trial on primary care patients with venous leg ulcers and pressure ulcers].
    Capillas Pérez R; Cabré Aguilar V; Gil Colomé AM; Gaitano García A; Torra i Bou JE
    Rev Enferm; 2000 Jan; 23(1):17-24. PubMed ID: 10788945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of 4% Hibiscus rosa-sinensis Leaf Extract Ointment as an Adjunct Treatment to Compression Stockings on the Closure of Venous Leg Ulcers: A Pilot Study.
    Maralit Bruan MJ; Tianco EA
    Wounds; 2019 Sep; 31(9):236-241. PubMed ID: 31298659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compression for venous leg ulcers.
    O'Meara S; Cullum NA; Nelson EA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000265. PubMed ID: 19160178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
    Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
    J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enamel matrix proteins; old molecules for new applications.
    Lyngstadaas SP; Wohlfahrt JC; Brookes SJ; Paine ML; Snead ML; Reseland JE
    Orthod Craniofac Res; 2009 Aug; 12(3):243-53. PubMed ID: 19627527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.